CHAR Technologies (YES) Q4 2025 earnings summary

Executive summary

• Transitioned Thorold project from pilot to commercialization, resulting in a $4.1M gain on contribution to joint venture and a reduction in liabilities of nearly $11M.

• Secured key partnerships, including a $2M investment from BMI Group and $8M into the Thorold Project, with a further $10M commitment to the Espanola Biocarbon project.

• Achieved commercial biocarbon production at Thorold and completed a global first in PFAS destruction via high temperature pyrolysis in Baltimore.

Financial highlights

• Total assets decreased by $6.5M year-over-year, from $15.4M to $8.9M.

• Total liabilities decreased by $10.9M, from $14.9M to $4.0M.

• Shareholders' equity increased by $4.4M, from $0.5M to $4.9M.

• Revenue was $2.2M, down from $3.2M year-over-year.

• Gross profit rose to $0.85M from $0.63M; net loss before taxes improved to ($1.1M) from ($7.5M).

• Recorded a $4.1M gain on contribution to joint venture.

Outlook and guidance

• Advancing engineering and design for the Espanola biocarbon project, with BMI's $10M commitment contingent on study completion.

• Focused on scaling up commercial production and expanding project pipeline.